PT789764E - Nova familia de inibidores de protease e outras substancias biologicas activas - Google Patents

Nova familia de inibidores de protease e outras substancias biologicas activas

Info

Publication number: PT789764E
Authority: PT; Portugal
Prior art keywords: relates; inhibitors; protease inhibitors; biological substances; new family
Prior art date: 1994-10-28

Application number

PT95937853T

Other languages

English (en)

Inventor

Gerard Voerman

Original Assignee

Vitaleech Bioscience N V

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-28

Filing date

1995-10-27

Publication date

2002-06-28

1995-10-27 Application filed by Vitaleech Bioscience N V filed Critical Vitaleech Bioscience N V

2002-06-28 Publication of PT789764E publication Critical patent/PT789764E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Communicable Diseases (AREA)
Biophysics (AREA)
Hematology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Genetics & Genomics (AREA)
Endocrinology (AREA)
Tropical Medicine & Parasitology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Obesity (AREA)
Immunology (AREA)
Virology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PT95937853T 1994-10-28 1995-10-27 Nova familia de inibidores de protease e outras substancias biologicas activas PT789764E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP94117053		1994-10-28
EP95103637		1995-03-14

Publications (1)

Publication Number	Publication Date
PT789764E true PT789764E (pt)	2002-06-28

Family

ID=26135896

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT95937853T PT789764E (pt)	1994-10-28	1995-10-27	Nova familia de inibidores de protease e outras substancias biologicas activas

Country Status (11)

Country	Link
US (1)	US6239106B1 (pt)
EP (1)	EP0789764B1 (pt)
JP (1)	JP4278175B2 (pt)
AT (1)	ATE211765T1 (pt)
AU (1)	AU3870195A (pt)
CA (1)	CA2203827A1 (pt)
DE (1)	DE69524971T2 (pt)
DK (1)	DK0789764T3 (pt)
ES (1)	ES2171563T3 (pt)
PT (1)	PT789764E (pt)
WO (1)	WO1996013585A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997017981A1 (en) *	1995-11-13	1997-05-22	Gerard Voerman	Anti-viral isolates obtainable from leeches
AUPO427596A0 (en) *	1996-12-20	1997-01-23	Cooperative Research Centre For Tropical Plant Pathology	Anti-microbial protein
EP0875564A1 (en) *	1997-05-02	1998-11-04	Gerard Voerman	Biologically active extract from the leech 'Limnatis nilotica'
FR2763944B1 (fr) *	1997-06-03	2000-12-15	Centre Nat Rech Scient	Nouveaux derives de coumarines, leurs procedes de preparation et leur application comme medicaments en tant qu'inhibiteurs de proteases
US6232287B1 (en) *	1998-03-13	2001-05-15	The Burnham Institute	Molecules that home to various selected organs or tissues
BR0009074A (pt) *	1999-03-18	2002-01-02	Merck Patent Gmbh	Proteìna para bloquear adesão de plaqueta
WO2015018840A2 (en) *	2013-08-05	2015-02-12	Gerard Voerman	Novel means to decrease the negative effects of smoking
WO2016020070A1 (en) *	2014-08-05	2016-02-11	Gerard Voerman	Mutants of leech derived neutrophil elastase inhibitors and uses thereof
CN105646702B (zh) *	2016-04-13	2019-03-01	中国科学院昆明动物研究所	菲牛蛭Kazal型胰蛋白酶抑制剂Bdellin-HM及其编码基因和应用
JP2020531586A (ja) *	2017-08-27	2020-11-05	アンタイ−ヴァイラルテクノロジーズ，エルエルシー	合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物
US11262125B2 (en) *	2018-01-02	2022-03-01	Praxair Technology, Inc.	System and method for flexible recovery of argon from a cryogenic air separation unit
WO2022232516A1 (en) *	2021-04-30	2022-11-03	The Regents Of The University Of California	Cartilage treatment for use in eyelid reconstruction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL86857A (en) *	1988-06-24	1994-04-12	Yissum Res Dev Co	Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same
US5783421A (en) *	1993-04-09	1998-07-21	Bio-Technology General Corp.	DNA encoding novel polypeptide having Factor Xa inhibitory activity

1995
- 1995-10-27 WO PCT/EP1995/004223 patent/WO1996013585A1/en active IP Right Grant
- 1995-10-27 US US08/836,686 patent/US6239106B1/en not_active Expired - Lifetime
- 1995-10-27 JP JP51431496A patent/JP4278175B2/ja not_active Expired - Fee Related
- 1995-10-27 DK DK95937853T patent/DK0789764T3/da active
- 1995-10-27 AU AU38701/95A patent/AU3870195A/en not_active Abandoned
- 1995-10-27 AT AT95937853T patent/ATE211765T1/de active
- 1995-10-27 EP EP95937853A patent/EP0789764B1/en not_active Expired - Lifetime
- 1995-10-27 CA CA002203827A patent/CA2203827A1/en not_active Abandoned
- 1995-10-27 ES ES95937853T patent/ES2171563T3/es not_active Expired - Lifetime
- 1995-10-27 DE DE69524971T patent/DE69524971T2/de not_active Expired - Lifetime
- 1995-10-27 PT PT95937853T patent/PT789764E/pt unknown

Also Published As

Publication number	Publication date
JPH10509589A (ja)	1998-09-22
WO1996013585A1 (en)	1996-05-09
DE69524971D1 (de)	2002-02-14
DE69524971T2 (de)	2002-08-29
CA2203827A1 (en)	1996-05-09
AU3870195A (en)	1996-05-23
US6239106B1 (en)	2001-05-29
ATE211765T1 (de)	2002-01-15
JP4278175B2 (ja)	2009-06-10
EP0789764A1 (en)	1997-08-20
DK0789764T3 (da)	2002-04-22
EP0789764B1 (en)	2002-01-09
ES2171563T3 (es)	2002-09-16

Similar Documents

Publication	Publication Date	Title
DE69417252D1 (de)	1999-04-22	Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
DE69034261D1 (de)	2009-02-12	Antikörper gegen VLA-4
RU95110871A (ru)	1997-06-10	Способы определения нуклеотидной последовательности
BG103977A (en)	2000-11-30	Low molecular rotamase enzymic activity inhibitors
MX9708438A (es)	1998-06-28	Proteina principal de la membrana externa de moraxella, de alto peso molecular.
NO964976L (no)	1997-01-23	Kopolymer-1-forbedringer kopolymerpreparater
PT789764E (pt)	2002-06-28	Nova familia de inibidores de protease e outras substancias biologicas activas
DE69410254D1 (de)	1998-06-18	Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
ATE287963T1 (de)	2005-02-15	Pseudomonas exotoxin - myelin basisches protein chimäre proteine
PT830130E (pt)	2004-11-30	Enzima de conversao de tnf-alfa
EP0754229A1 (en)	1997-01-22	Alfamin: a human serum albumin-like protein
AR002742A1 (es)	1998-04-29	Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
EA200100700A1 (ru)	2001-12-24	Гены и белки и их применение
FI961202A (fi)	1996-03-14	Grb3-3-geeni, sen variantteja ja niiden käyttöjä
DE68917837D1 (de)	1994-10-06	Peptid-Verbindungen.
YU200091A (sh)	1994-06-10	Delecioni mutanti ahasarezistentni na herbicide
AU3595489A (en)	1989-12-07	Amblyommin, a new active substance for anticoagulant therapy
EP1251176A3 (en)	2002-12-18	Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
WO1996025183A3 (en)	1996-10-10	Ophthalmic compositions including peptides and peptide derivatives and methods for using same
TR199700842T1 (xx)	1998-01-21	�nsan DNase I Varyantlar�.
AU5163598A (en)	1998-05-22	Novel hepatitis b inhibitors
HUP0001184A2 (hu)	2000-08-28	"Basic Helix-Loop-Helix" (bHLH) családba tartozó polipeptidek és a megfelelő nukleinsav-szekvenciák
CA2086835A1 (en)	1992-02-01	Tissue plasminogen activator variants with decreased clearance
WO2002016568A3 (en)	2002-09-06	46863, a human methyltransferase and uses thereof
FR2654430B1 (fr)	1995-01-06	Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.